- Tytuł:
- 134P Impact of pre-operative MammaPrint/BluePrint use for final treatment decisions in patients with stage II/IIIa HR+/HER2- early-stage breast cancer eligible for neoadjuvant chemotherapy: The DETERMIND study
- Autorzy:
- Źródło:
- In ESMO Open May 2023 8(1) Supplement 4
Czasopismo naukowe